Management of Cardiogenic Shock Due to Acute Coronary Syndromes

Despite advances in the treatment of patients with acute coronary syndromes, there has been no significant decrease in the incidence of cardiogenic shock, while its mortality remains frustratingly high. Shock is a progressive state of hypotension (systolic blood pressure

Saved in:
Bibliographic Details
Published in:Angiology 2005-03, Vol.56 (2), p.123-130
Main Authors: Bouki, Konstantina P., Pavlakis, Georgios, Papasteriadis, Evaggelos
Format: Article
Language:English
Subjects:
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiotonic Agents - therapeutic use
Coronary Disease - complications
Coronary Disease - mortality
Coronary Disease - therapy
Coronary heart disease
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Heart
Humans
Injuries of the limb. Injuries of the spine
Intra-Aortic Balloon Pumping
Medical sciences
Myocardial Revascularization
Platelet Aggregation Inhibitors - therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors
Shock, Cardiogenic - etiology
Shock, Cardiogenic - mortality
Shock, Cardiogenic - therapy
Survival Rate
Syndrome
Traumas. Diseases due to physical agents
Treatment Outcome
Vasoconstrictor Agents - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite advances in the treatment of patients with acute coronary syndromes, there has been no significant decrease in the incidence of cardiogenic shock, while its mortality remains frustratingly high. Shock is a progressive state of hypotension (systolic blood pressure
ISSN:0003-3197
1940-1574
DOI:10.1177/000331970505600201